Common variants in IL-1RN, IL-1β and TNF-α and the risk of ovarian cancer: a case control study

Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorp...

Full description

Saved in:
Bibliographic Details
Published inCentral-European journal of immunology Vol. 42; no. 2; pp. 150 - 155
Main Authors Ahmed, Amira Ben, Zidi, Sabrina, Sghaier, Ikram, Ghazouani, Ezzeddine, Mezlini, Amel, Almawi, Wassim, Loueslati, Besma Yacoubi
Format Journal Article
LanguageEnglish
Published Poland Termedia Publishing House 01.01.2017
Polish Society of Experimental and Clinical Immunology
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1 (-511C>T), IL-1RN VNTR, TNF- (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. Study subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1 (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF- -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. The significant association between IL-1RN VNTR, IL1- (-511), TNF- (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis.
AbstractList Aim of the study: Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1 (-511C>T), IL-1RN VNTR, TNF- (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. Methods and results: Study subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1 (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF- -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. Conclusions: The significant association between IL-1RN VNTR, IL1- (-511), TNF- (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis.
Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1 (-511C>T), IL-1RN VNTR, TNF- (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. Study subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1 (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF- -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. The significant association between IL-1RN VNTR, IL1- (-511), TNF- (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis.
AIM OF THE STUDYSeveral studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to play an important role in the development of malignancies, including ovarian cancer (OC). Here we investigated the relationship between polymorphisms in IL-1β (-511C>T), IL-1RN VNTR, TNF-α (-308G>A), and TNF RII (-322 VNTR) and OC risk in Tunisian women. METHODS AND RESULTSStudy subjects comprised 62 OC patients and 126 healthy women. Genotyping was done from genomic DNA obtained from blood simple by PCR. Positive association between IL-1RN (-VNTR) A1 allele (p = 0.0069; OR = 2.04; 95% CI:1.17-3.58) and OC risk, while negative association was seen with the A3 allele (P = 0.0034; OR = 0.09; 95% CI: 0.00-0.64), suggesting a protective role by the A3 allele. For IL-1β (-511C>T), homozygous C/C genotype was associated with significantly increased risk of OC (p = 0.0002; OR = 4.14; 95% CI: 1.77-9.76), while heterozygote C/T genotype was linked with reduced risk of OC (p = 0.0033; OR = 0.40; 95% CI: 0.20-0.78). Furthermore, TNF-α -308A allele was significantly associated with heightened risk of OC (p = 0.016; OR = 1.70; 95% CI: 1.08-2.69), and homozygote G/G genotype was associated with decreased risk of OC (p = 0.0018; OR = 0.25; 95% CI: 0.09-0.66). In contrast, TNFRII (-322 VNTR) polymorphism was not associated with altered OC risk in the studied group. CONCLUSIONSThe significant association between IL-1RN VNTR, IL1-β (-511), TNF-α (-308) and OC susceptibility in Tunisian women confirms a role for altered inflammatory response in ovarian cancer pathogenesis.
Author Mezlini, Amel
Sghaier, Ikram
Ahmed, Amira Ben
Zidi, Sabrina
Almawi, Wassim
Ghazouani, Ezzeddine
Loueslati, Besma Yacoubi
AuthorAffiliation 1 Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia
2 Laboratory of Immunology, Military Hospital of Tunis, Tunis, Tunisia
3 Salah Azeiz Oncology Institute, Tunis, Tunisia
4 Department of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain
AuthorAffiliation_xml – name: 4 Department of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain
– name: 2 Laboratory of Immunology, Military Hospital of Tunis, Tunis, Tunisia
– name: 1 Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia
– name: 3 Salah Azeiz Oncology Institute, Tunis, Tunisia
Author_xml – sequence: 1
  givenname: Amira Ben
  surname: Ahmed
  fullname: Ahmed, Amira Ben
  organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia
– sequence: 2
  givenname: Sabrina
  surname: Zidi
  fullname: Zidi, Sabrina
  organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia
– sequence: 3
  givenname: Ikram
  surname: Sghaier
  fullname: Sghaier, Ikram
  organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia
– sequence: 4
  givenname: Ezzeddine
  surname: Ghazouani
  fullname: Ghazouani, Ezzeddine
  organization: Laboratory of Immunology, Military Hospital of Tunis, Tunis, Tunisia
– sequence: 5
  givenname: Amel
  surname: Mezlini
  fullname: Mezlini, Amel
  organization: Salah Azeiz Oncology Institute, Tunis, Tunisia
– sequence: 6
  givenname: Wassim
  surname: Almawi
  fullname: Almawi, Wassim
  organization: Department of Medical Biochemistry, Arabian Gulf University, Manama, Bahrain
– sequence: 7
  givenname: Besma Yacoubi
  surname: Loueslati
  fullname: Loueslati, Besma Yacoubi
  organization: Department of Biology, Faculty of Sciences of Tunis, Laboratory of Mycology, Pathologies and Biomarkers: LR16ES05, El Manar University, Tunis, Tunisia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28860932$$D View this record in MEDLINE/PubMed
BookMark eNpdksluFDEQhlsoiCxw5oYsceFAT9pLe-EQCY0IjDQKEgpnq9pL0kO3HezuSHkseJA8E56ZEBFOVbL_-qrK_o-rgxCDq6rXuFm0GLNT4zb9gjRYLLiiLX9WHWHOWM0wYQclZ4TXVGFyWB3nvGkarrBUL6pDIiVvFCVHFSzjOMaAbiH1EKaM-oBW6xp_u3i_i_e_EQSLLi_O6_tfu3S6dij1-QeKHsV9GTIQjEsfEJQsO2RimFIcUJ5me_eyeu5hyO7VQzypvp9_ulx-qddfP6-WH9e1YVJMtWfSem4ajtvOEiE5qM4KqyzwTkLnvfGeNox1nHEGzFhoHZdKWGBOEtrSk2q159oIG32T-hHSnY7Q691BTFca0tSbwenOWpBtq1RBM-8a6S3lGAsChmNDXWGd7Vk3czc6a1zZB4Yn0Kc3ob_WV_FWt62gUooCePcASPHn7PKkxz4bNwwQXJyzxqo05FRyUqRv_5Nu4pxCeaqiIkKJMikvqtO9yqSYc3L-cRjc6K0V9NYKemsFvbNCqXjz7w6P-r9_T_8AMJGx5w
CitedBy_id crossref_primary_10_1016_j_gene_2022_146288
crossref_primary_10_1007_s00604_022_05595_w
crossref_primary_10_1007_s11033_022_07297_1
crossref_primary_10_1007_s40487_018_0089_z
crossref_primary_10_1177_2152656719860820
crossref_primary_10_1158_1055_9965_EPI_21_0139
crossref_primary_10_4081_oncol_2019_413
crossref_primary_10_1186_s12866_020_02072_3
crossref_primary_10_1155_2018_7569809
crossref_primary_10_3390_cancers13030564
crossref_primary_10_1111_1348_0421_12774
crossref_primary_10_1016_j_intimp_2022_108577
crossref_primary_10_3390_cancers15020360
crossref_primary_10_1016_j_genrep_2022_101539
crossref_primary_10_1111_imm_13486
ContentType Journal Article
Copyright Copyright Termedia Publishing House 2017
Copyright: © 2017 Polish Society of Experimental and Clinical Immunology 2017
Copyright_xml – notice: Copyright Termedia Publishing House 2017
– notice: Copyright: © 2017 Polish Society of Experimental and Clinical Immunology 2017
DBID NPM
AAYXX
CITATION
3V.
7RV
7T5
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.5114/ceji.2017.69356
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing & Allied Health Database
Immunology Abstracts
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Nursing & Allied Health Premium
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1644-4124
EndPage 155
ExternalDocumentID oai_doaj_org_article_bdda855996b84fe08fd361172ac61c3e
10_5114_ceji_2017_69356
28860932
Genre Journal Article
GroupedDBID ---
29B
2NK
2WC
3EA
3V.
53G
5GY
5VS
7RV
7X7
88E
8AO
8FE
8FH
8FI
8FJ
ABDBF
ABMXE
ABUWG
ACPRK
ADBBV
ADRAZ
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BKEYQ
BPHCQ
BVXVI
CCPQU
DIK
EOJEC
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IPNFZ
KQ8
LK8
M1P
M48
M7P
NAPCQ
NPM
OBODZ
OK1
P2P
P6G
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
TR2
UKHRP
Y2W
AAYXX
CITATION
7T5
7XB
8FK
AZQEC
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c487t-f48df6c0615bd2786a9bd7d9da6b8abffcff3044b6464a4cda5e6897da4e82353
IEDL.DBID RPM
ISSN 1426-3912
IngestDate Mon Oct 28 19:36:39 EDT 2024
Tue Sep 17 20:46:38 EDT 2024
Fri Aug 16 10:21:23 EDT 2024
Thu Oct 10 16:00:43 EDT 2024
Fri Aug 23 01:08:30 EDT 2024
Sat Sep 28 08:07:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords interleukin-1
tumor necrosis factor
ovarian cancer
gene variants
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c487t-f48df6c0615bd2786a9bd7d9da6b8abffcff3044b6464a4cda5e6897da4e82353
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573887/
PMID 28860932
PQID 1927978556
PQPubID 2028857
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_bdda855996b84fe08fd361172ac61c3e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5573887
proquest_miscellaneous_1936163862
proquest_journals_1927978556
crossref_primary_10_5114_ceji_2017_69356
pubmed_primary_28860932
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Poland
PublicationPlace_xml – name: Poland
– name: Warsaw
PublicationTitle Central-European journal of immunology
PublicationTitleAlternate Cent Eur J Immunol
PublicationYear 2017
Publisher Termedia Publishing House
Polish Society of Experimental and Clinical Immunology
Publisher_xml – name: Termedia Publishing House
– name: Polish Society of Experimental and Clinical Immunology
References 14633943 - Gut. 2003 Dec;52(12):1684-9
25113639 - Pathol Oncol Res. 2015 Apr;21(2):339-45
8188271 - Genomics. 1994 Jan 15;19(2):382-4
12445604 - J Soc Gynecol Investig. 2002 Nov-Dec;9(6):386-90
9710237 - Eur J Immunol. 1998 Aug;28(8):2598-602
11196666 - Genes Immun. 1999 Nov;1(2):164-5
22562260 - Int J Colorectal Dis. 2013 Mar;28(3):431-2
17141301 - Gynecol Oncol. 2007 Mar;104(3):680-5
12548511 - Liver Transpl. 2003 Feb;9(2):170-81
20144842 - Gynecol Oncol. 2010 May;117(2):366-72
20450741 - Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Mar;44(3):209-14
15581980 - Gynecol Oncol. 2004 Dec;95(3):672-9
12463079 - AORN J. 2002 Nov;76(5):792-802, 805-6; quiz 807-10
1492596 - J Biol Regul Homeost Agents. 1992 Jul-Sep;6(3):103-7
23049925 - PLoS One. 2012;7(9):e46017
10544444 - Transpl Immunol. 1999 Jun;7(2):127-8
24969564 - Tumour Biol. 2014 Oct;35(10):9693-9
22349527 - Cytokine. 2012 May;58(2):133-47
14504049 - Ann Oncol. 2003 Oct;14(10):1501-4
12209358 - Genes Immun. 2002 Sep;3(6):313-30
9096369 - Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9
1448359 - Nurs Clin North Am. 1992 Dec;27(4):835-45
14555214 - Biochem Pharmacol. 2003 Oct 15;66(8):1403-8
23704929 - PLoS One. 2013 May 21;8(5):e63654
9646173 - Int Rev Immunol. 1998;16(5-6):457-99
8598468 - J Immunol. 1996 Jan 1;156(1):238-45
20882404 - Breast Cancer Res Treat. 2011 Apr;126(3):763-70
21107607 - J Cancer Res Clin Oncol. 2011 Jun;137(6):947-52
11229684 - Lancet. 2001 Feb 17;357(9255):539-45
References_xml
SSID ssj0069189
ssib008506718
Score 2.170921
Snippet Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines were shown to...
Aim of the study: Several studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines...
AIM OF THE STUDYSeveral studies implicated altered inflammatory response in the susceptibility to ovarian cancer, and polymorphisms in inflammatory cytokines...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 150
SubjectTerms Alleles
Clinical Immunology
gene variants
Genotype & phenotype
Genotyping
Health risk assessment
Heterozygotes
Inflammation
Interleukin 1
Interleukin 1 receptors
Ovarian cancer
Polymerase chain reaction
Tumor necrosis factor
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuiG8CBRmJAwdMk9ixHW6AWBWE9oBaqbdo_CWWQ1K1WyR-FvyQ_iZm7HTZRUhcOMVKnMR5nthv4skbxp5bl1RbQxQauYdQISThonWi65OxilZqIEdbLPXhsfp40p1spfqimLAiD1yAO3AhgCVZLO2sSrG2KUjd4LQLXjdexjz61v2WM0WWRDps5vd6AjYkJ8NrcD4Ssm_aIvKDZEMd-Ph1RSFe5pXuJeWx3pqfsoz_37jnnyGUW3PS4ha7OZNJ_qY8xG12LY532PWSXvL7XQb098c08m_oD1O4C1-N_MMn0Xxevszby58cxsCPlgtx-SMXkQ1yCjbnU-JTOY17souz1xywdB75HNvOsy7tPXa8eH_07lDMKRWER89kLZKyIWlPPMaF1lgNvQsm9AEQXnAp-ZRkrZTTSitQPkAXte1NABVtKzt5n-2N0xgfMq5cDzV455BSqBY7BiyiESWkztmmjhV7cQXkcFqUMwb0OAjzgTAfCPMhY16xtwT0phpJXucdaAjDbAjDvwyhYvtX3TTM7-H5gPzVoJ_c0T2ebQ7jG0TLIjDG6YLq4HVwGNJtxR6UXt20pLVW10hxK2Z2-nunqbtHxtWXrNLddUbiCP7ofzzbY3aD0CqffvbZ3vrsIj5BMrR2T7Pd_wIdWQZk
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest_Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIlLxZuUgozEgQOmSfwMFwSIVUFoD6iV9hb5WZZDUna3SPws-CH9Tcw42d0uQpwSxU48Go_H33gmM4Q8Ny6JurSRKcAeTISQmIvGMdkkbQR6amyOtpiq41PxaSZn44HbcgyrXOvErKhD7_GM_AiQiAaLR0r15vw7w6pR6F0dS2hcJzequlQo1Xq23U4xG5veehWAnFwSr4JdifGmqodUPwA5xJGP3-YY6KVfqYZjNesru1RO5v8vBPp3IOWVnWlym-yPkJK-HWTgDrkWu7vk5lBk8uc9YvEfkL6jP8AqxqAXOu_ox8-s-jJ9ma-Xv6ntAj2ZTtjlr3wLmJBiyDntE-2H16hH6Vi8phbulpGOEe40Z6e9T04nH07eH7OxsALzYJ-sWBImJOURzbhQa6Ns44IOTbDKGetS8inxUginhBJW-GBlVKbRwYpoai75A7LX9V18RKhwjS2tdw6AhahjaawBbkRuk3SmKmNBXqwZ2Z4P-TNasDuQ5y3yvEWet5nnBXmHjN50w8TX-UG_OGvHddS6EKzBLGlAqUgwXgpcVYDCrFeV5zDe4Xqa2nE1Ltut7BTk2aYZ1hE6R2wX-wvsA98BZaTqgjwcZnVDSW2MKgHoFkTvzPcOqbst3fxrztUtpeagxw_-T9Zjcgv5MBztHJK91eIiPgGws3JPs0T_AaBj_Ww
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access(OpenAccess)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagCIkLory6UJCROHDASxI_wwVRxKogtAfUlXqz7NiGrVAC2y2iPwt-SH8TM05220V75BQrduLJ59c38XiGkOfGJ1EVLjIF3IOJEBLz0Xgm66SNwJ0al60tpupwJj4ey-PLcEADgKdbVTuMJzVbfBv_-nH-BgY88Ncx0AXxqoknczTS0mNVc6mukxsVngNCO74rXB9ds-nLLQaQLcfHK2GJYrwuq97vz7YXbixZ2bP_Njr6r1XllWVqcofcHvglfdt3iF1yLbZ3yc0-4uT5PeLwQEjX0p-gIqMFDJ239MMnVn6evszXiz_UtYEeTSfs4ndOAkGkaH9Ou0S7_jHaYFdZvKYOUqeRDubuNLuqvU9mk_dH7w7ZEGWBNaCsLFkSJiTVILXxodJGudoHHerglDfOp9SkxAshvBJKONEEJ6MytQ5ORFNxyR-QnbZr4x6hwteucI33wDJEFQvjDKARuUvSm7KII_JiBaT93jvTsKCEIOYWMbeIuc2Yj8gBAr0uhl6w841u8cUOg8r6EJxBl2kgqUhQXwpclUDJXKPKhkN9-6tmsqueZYHSalCdJdbxbJ0Ngwp3SlwbuzMsA--BmUlVI_Kwb9W1JJUxqgDWOyJ6o703RN3Maedfs-NuKTWHSf3R__i2x-QWotX_DdonO8vFWXwC_Gjpn-Z-_xfIgQ3J
  priority: 102
  providerName: Scholars Portal
Title Common variants in IL-1RN, IL-1β and TNF-α and the risk of ovarian cancer: a case control study
URI https://www.ncbi.nlm.nih.gov/pubmed/28860932
https://www.proquest.com/docview/1927978556
https://search.proquest.com/docview/1936163862
https://pubmed.ncbi.nlm.nih.gov/PMC5573887
https://doaj.org/article/bdda855996b84fe08fd361172ac61c3e
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaIiQuiDcLZWUkDhzw7ibxK9xo1VVBdFVVrbS3yM-yiCbVdovEz4If0t_EjJMsbMWJSxLFdjwaj-Nv7M9jQt5oG3k-MYFJwB6Mex-ZDdoyUUalOa7UmMS2mMnDM_5pLuZbRPR7YRJp39nFqP52MaoXXxK38vLCjXue2Pj4aF8IVUDnGG-TbTDQWy46hmBTf5YSQIZ0Dl4GQxEryixv4_sAzuBjF74ukN2lRrIsBJ5mlGstwcfPN0apFMz_Xwj0NpHyr5Fp-oDc7yAl_dCK_pBshfoRudseMvnjMTG4B6Sp6XfwipH0Qhc1_fiZZSezd-l-84ua2tPT2ZTd_EyPgAkpUs5pE2nTFqMOrWP5nhp4ugq0Y7jTFJ32CTmbHpzuH7LuYAXmwD9Zsci1j9IhmrE-V1qa0nrlS2-k1cbG6GIsJpxbySU33HkjgtSl8oYHnReieEp26qYOzwnltjQT46wFYMHzMNFGgzZCYaKwOpuEAXnbK7K6bONnVOB3oPorVH-F6q-S-gdkDxW9zoaBr9OLZnledc1fWe-NxihpICmPUF_0hcwAhRknM1dAfbt9M1Vdb7yqAMUq8JYF1vF6nQz9CBdHTB2aa8wD34GfkcwH5FnbqmtJeqsYELXR3huibqaA6aZY3Z2pvvjvki_JPVRRO-uzS3ZWy-vwCnDQyg7B-udqSO7sHcyOT4ZpNgGuR1wPU4_4DW_PCrk
link.rule.ids 230,315,730,783,787,867,888,2109,2228,12069,21401,24331,27937,27938,31732,31733,33757,33758,43323,43818,53805,53807
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYIL4rlbWMBIHDhgNg_HdrggQFRdKD2grtSb5Sd0D8nSdpH4WfBD9jcx46TtFiFOiWInHo3H9jf25BtCnisbeZGZwARgD8a9j8wGZVlVR6k4ntSYFG0xEaMT_nFWzfoNt2UfVrmeE9NE7VuHe-RHgEQkeDxVJd6cfWeYNQpPV_sUGlfJNeThQjuXs-1yimxscnuqAOKklHg5rEqsrPOio_oByMGPXDidY6CXfCXqErNZX1qlEpn_vxDo34GUl1am4W1yq4eU9G1nA3fIldDcJde7JJM_7xGD_4C0Df0BXjEGvdB5Q4_HLP8yeZmuF7-paTydTobs4le6BUxIMeSctpG23WvUoXUsXlMDd8tA-wh3mthp75OT4Yfp-xHrEyswB_7JikWufBQO0Yz1hVTC1NZLX3sjrDI2RhdjmXFuBRfccOdNFYSqpTc8qKKsygdkr2mbcEAot7XJjLMWgAUvQqaMAm2E0sTKqjwLA_JirUh91vFnaPA7UOcada5R5zrpfEDeoaI31ZD4Oj1oF191P4609d4oZEkDSXmE9qIvRQ4ozDiRuxLaO1x3k-5H41JvbWdAnm2KYRzh4YhpQnuOdeA7MBmJYkD2u17dSFIoJTIAugMid_p7R9Tdkmb-LXF1V5UsYR5_-H-xnpIbo-nnsR4fTz49IjdRJ902zyHZWy3Ow2MAPiv7JFn3H5uTAGI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWgCMSG92OggJFYsMB52o7DDgqjFsqoQq1UsbH8pFNoMprOIMFfwYf0m7h2MkNnxKqrRIkTO77X8bnxybkIvRDa0yJTjnDAHoRa64l2QhNW-0rQsFKjIttixLcP6IdDdngu1Vck7Rs9TprvJ0kzPorcysmJSRc8sXTv0xZjVQmDI51Yn15GV1gQTV8L1IMQW_VvQQFaErPh5TAhkbLOi07lB9AGTY07HgeOV5XwumQhp1EhBIdIv1iZq6Kk__9w6Dqd8tz8NLyJviyerKOlfEvmM52YX2uijxd69FvoRo9a8ZuuyG10yTV30NUuj-XPu0iF30zaBv-AwDvwavC4wTu7JP88ehW3Z3-waizeHw3J2e-4C7ATB1Y7bj1uu8uwCQ44fY0V7J063JPocRTAvYcOhu_3t7ZJn7uBGAiBZsRTYT03ATBpW1SCq1rbytZWcS2U9t54X2aUak45VdRYxRwXdWUVdaIoWXkfbTRt4x4iTHWtMmW0BuxCC5cJJaCrXak80yLP3AC9XFhJTjqJDgmhTbCtDLaVwbYy2naA3gYrLosFbe14oJ1-lX03S22tEkGIDVpKPdTnbclzAHrK8NyUUN_mwgdkP-BPJQDlCgJyFup4vjwNQzWsv6jGtfNQBu4D7zteDNCDzmWWLVm43ABVK8600tTVM-AiUQ68d4lHF77yGbq2924od3dGHx-j66G3um9Mm2hjNp27J4C6ZvppHF9_AXTfKus
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Common+variants+in+IL-1RN%2C+IL-1%CE%B2+and+TNF-%CE%B1+and+the+risk+of+ovarian+cancer%3A+a+case+control+study&rft.jtitle=Central-European+journal+of+immunology&rft.au=Amira+Ben+Ahmed&rft.au=Sabrina+Zidi&rft.au=Ikram+Sghaier&rft.au=Ezzeddine+Ghazouani&rft.date=2017-01-01&rft.pub=Termedia+Publishing+House&rft.issn=1426-3912&rft.eissn=1644-4124&rft.volume=42&rft.issue=2&rft.spage=150&rft.epage=155&rft_id=info:doi/10.5114%2Fceji.2017.69356&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bdda855996b84fe08fd361172ac61c3e
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1426-3912&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1426-3912&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1426-3912&client=summon